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Summary
 
The differentiation of intestinal intraepithelial lymphocytes (IEL) remains controversial, which
may be due in part to the phenotypic complexity of these T cells. We have investigated here
the development of IEL in mice on the recombination activating gene (RAG)-2
 
2
 
/
 
2
 
 back-
ground which express a T cell antigen receptor (TCR) transgene specific for an H-Y peptide
presented by D
 
b
 
 (H-Y/D
 
b
 
 
 
3
 
 RAG-2
 
2
 
 mice). In contrast to the thymus, the small intestine in
female H-Y/D
 
b
 
 
 
3
 
 RAG-2
 
2
 
 mice is severely deficient in the number of IEL; TCR transgene
 
1
 
CD8
 
aa
 
 and CD8
 
ab
 
 are virtually absent. This is similar to the number and phenotype of IEL
in transgenic mice that do not express the D
 
b
 
 class I molecule, and which therefore fail positive
selection. Paradoxically, in male mice, the small intestine contains large numbers of TCR
 
1
 
 IEL
that express high levels of CD8
 
aa
 
 homodimers. The IEL isolated from male mice are func-
tional, as they respond upon TCR cross-linking, although they are not autoreactive to stimula-
tor cells from male mice. We hypothesize that the H-Y/D
 
b
 
 TCR fails to undergo selection in
IEL of female mice due to the reduced avidity of the TCR for major histocompatibility com-
plex peptide in conjunction with the CD8
 
aa
 
 homodimers expressed by many cells in this lin-
eage. By contrast, this reduced TCR/CD8
 
aa
 
 avidity may permit positive rather than negative
selection of this TCR in male mice. Therefore, the data presented provide conclusive evidence
that a TCR which is positively selected in the thymus will not necessarily be selected in IEL,
and furthermore, that the expression of a distinct CD8 isoform by IEL may be a critical deter-
minant of the differential pattern of selection of these T cells.
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T
 
he development of T cells in the thymus ultimately re-
sults in one of three fates: negative selection leading to
deletion of autoreactive clones, positive selection leading to
thymocyte survival and emigration, or a lack of selection
that also results in programmed cell death of thymocytes
(1). Although there is significant evidence consistent with
the extrathymic differentiation of intestinal intraepithelial
lymphocytes (IEL),
 
1
 
 it has been difficult to clearly define
the requirements for the development and selection of
these cells (2–5). Part of this challenge arises from the phe-
notypic complexity of IEL, and the still undefined lineage
relationships between some of the phenotypic subsets (6).
Besides the TCR 
 
gd
 
1
 
 IEL, five TCR 
 
ab
 
1
 
 phenotypes
have been reported in IEL based on their expression pat-
tern of coreceptor molecules (6). In addition to the two
subsets predominant in circulating T lymphocytes outside
of the intestine, CD4
 
1
 
 and CD8
 
ab
 
1
 
 single positive cells,
IEL also contain unique TCR 
 
ab
 
1
 
 subsets that express
CD8
 
aa
 
 either alone or in combination with CD4 (CD4
 
1
 
,
CD8
 
aa
 
1
 
 double positive cells). Finally, as found elsewhere
in peripheral lymphoid tissues, there is a small population
of double negative (DN) IEL that do not express either
CD4 or CD8. Notably, in contrast to other peripheral T
cell populations, IEL of the small intestine are composed
predominantly of CD8
 
1
 
 single positive T cells, with ap-
proximately equal proportions of cells that express either
CD8
 
ab
 
 heterodimers or CD8
 
aa
 
 homodimers among the
TCR 
 
ab
 
1
 
 cells, whereas the TCR 
 
gd
 
1
 
 IEL are nearly ex-
clusively CD8
 
aa
 
1
 
 (7, 8).
 
1
 
Abbreviations used in this paper:
 
 IEL, intestinal intraepithelial lympho-
cyte(s); DN, double negative; LPL, lamina propria lymphocyte(s); RAG,
recombination activating gene; TAP, transporter associated with antigen
processing.
  
256
 
Differential Selection of IEL
 
Perhaps the best evidence in favor of some type of selec-
tion of TCR 
 
ab
 
 IEL comes from the analysis of 
 
b
 
2 micro-
globulin knockout mice (9). In these class I–deficient mice,
thymic selection of TCR 
 
ab
 
1
 
 CD8 single positive T cells
is almost completely inhibited. In the intestine of these
mice, normal numbers of TCR 
 
gd
 
1
 
 CD8
 
aa
 
 IEL can be
found, although the vast majority of CD8
 
aa
 
 single positive
and CD8
 
ab
 
 single positive TCR 
 
ab
 
1
 
 IEL are absent (10–
12). These data suggest that all TCR 
 
ab
 
1
 
 CD8
 
1
 
 IEL re-
quire class I molecules for their positive selection, like their
counterparts in the spleen and LN, although the data do
not determine if this positive selection occurred in the thy-
mus or elsewhere.
TCR transgenic mice can be used to study the positive
and negative selection of individual TCRs in the thymus
and in IEL. A useful and widely studied transgenic model
for the selection of CD8
 
1
 
 T cells involves expression of the
TCR derived from a clone reactive to a male-derived pep-
tide (H-Y) presented by the D
 
b
 
 class I molecule (H-Y/D
 
b
 
mice; reference 13). In male mice that express the D
 
b
 
 class I
gene, this TCR is autoreactive. As a result, thymocytes in
D
 
b
 
1
 
 male mice undergo extensive deletion, and these mice
have a small thymus with few double or single positive T
cells (14, 15). Interestingly, H-Y/D
 
b
 
 male TCR transgenic
mice do have significant numbers of TCR transgene
 
1
 
 cells
in the periphery, but these T lymphocytes are either DN or
CD8
 
a
 
low
 
b
 
low
 
 (15, 16). It has been proposed that the TCR
transgene
 
1
 
 cells in male mice may be derived from thy-
mocytes that have downregulated CD8 expression in order
to avoid negative selection, or that they may be 
 
gd
 
 lineage
cells that have been forced to express an 
 
ab
 
 TCR (17). By
contrast, female D
 
b
 
1
 
 transgenic mice lack the male antigen,
but in the thymus, they must express a peptide or peptides
that can positively select this TCR. As a consequence, the
thymus of female TCR transgenic mice is approximately
normal or somewhat larger than normal in size, and it has a
greatly increased number of CD8
 
ab
 
1
 
 single positive thy-
mocytes (18–20). Finally, in either male or female H-Y/D
 
b
 
TCR transgenic mice that do not express D
 
b
 
, the TCR
transgene does not undergo positive selection, and thy-
mocyte differentiation is blocked at the double positive
stage (18, 20).
To study the selection of a single TCR within IEL, sev-
eral groups have previously used the H-Y/D
 
b
 
 TCR trans-
genic mouse model (21–23). These investigations have re-
sulted in partially discordant outcomes. In one report, it
was concluded that the CD8
 
aa
 
 IEL subset was able to de-
velop exclusively in the male intestine of transgenic mice
(21). In a different report, this finding was challenged, as
the investigators found CD8
 
aa
 
 IEL development was able
to occur not only in male H-Y/D
 
b
 
 TCR transgenic mice,
but also in female H-Y/D
 
b
 
 TCR transgenic mice on either
the H-2D
 
b
 
 or D
 
d
 
 background (22). Most importantly, it
was concluded that positive selection of TCR transgene
 
1
 
CD8
 
ab
 
1
 
 IEL occurs via an extrathymic pathway in these
female transgenic mice (22). The issue of positive selection
of TCR 
 
ab
 
1
 
 CD8
 
ab
 
1
 
 IEL was not addressed in the other
investigation (21). Therefore, because of discordant results,
or the lack of corroborating results, the possibility of posi-
tive selection of TCR transgene
 
1
 
 IEL in these mice re-
mains unresolved.
Despite the use of transgenic TCR models aimed at gen-
erating monoclonal T cell populations in the two studies
cited above, the rearrangement of endogenous TCR genes,
particularly the rearrangement of 
 
a
 
 genes (21, 22, 24), pro-
vides a significant factor complicating the interpretation of
results. The H-Y/D
 
b
 
–specific TCR transgene may be par-
ticularly leaky, since in the above cited studies, most of the
IEL expressed endogenous TCR 
 
a
 
 chains (20, 25), and up
to 30% coexpressed 
 
gd
 
 TCRs on cells expressing one or
both of the H-Y/D
 
b
 
–specific TCR transgene chains (21).
In such a context, it is difficult to rigorously determine that
expression of the transgenic TCR leads to the selection of a
particular lymphocyte, despite expression of detectable lev-
els of both the transgene-encoded 
 
a
 
 and 
 
b
 
 chains by that
cell. The degree of endogenous TCR expression could be
one reason for the discrepancies described above. There-
fore, in this report, we have revisited this TCR transgenic
model of T cell selection, except that we have analyzed
truly monoclonal H-Y/D
 
b
 
–specific TCR transgenic mice
by crossing these mice onto the recombination activating
gene (RAG)-2–deficient background. The data we have
obtained demonstrate that a TCR positively selected in the
thymus is not necessarily also selected among the IEL. The
data also suggest that the CD8 isoform expressed may be an
important factor in the different patterns of selection of sin-
gle TCRs in the thymus and in the small intestine epithe-
lium.
 
Materials and Methods
 
Mice.
 
Mice transgenic for a TCR specific for a male-derived
peptide presented by D
 
b
 
 (H-Y/D
 
b
 
 transgenic mice [13]) were ob-
tained from Dr. Wendy Shores at the National Institutes of
Health (Bethesda, MD). RAG-2
 
2
 
/
 
2
 
 mice (26) were obtained
from Dr. Ellen Rothenberg, California Institute of Technology
(Pasadena, CA). Transporter associated with antigen processing
(TAP)-1
 
2
 
/
 
2
 
 mice (27) were obtained from Dr. Luc Van Kaer,
Vanderbilt University (Nashville, TN). H-Y/D
 
b
 
 
 
3
 
 RAG-2
 
2
 
mice were from the F2 generation of an intercross between H-Y/
D
 
b
 
 transgenic mice and RAG-2
 
2/2 mice. Identification of H-Y/
Db 3 RAG-22 mice was done by staining peripheral blood with
mAbs directed against Vb8 for the TCR transgene and CD4.
Mice with only Vb81, CD42 lymphocytes were selected, be-
cause all CD4 T cells are absent in RAG-22/2 mice with (Vb81)
or without the transgene. Doubly deficient and TCR transgenic
H-Y/Db 3 RAG-22 3 TAP-12 mice were obtained from the
F3 generation of an intercross between H-Y/Db 3 RAG-22
mice and TAP-12/2 mice. Typing of these mice required two
steps: (a) identification of RAG-2 and TAP-1 deficiencies was
done by staining peripheral blood with mAbs directed against Kb
and CD4. Kb2 (TAP-12/2) and CD42 (RAG-22/2) mice were
selected, and (b) identification of the H-Y/Db Vb8 transgene was
done by PCR typing. Primers used to identify the transgene b
chain spanned the V-D-J region. Sequences of the primers used
are 59, GACATTGAGCTGTAATCAGAC and 39, ACAGCG-
TTTCTGCACTGTTATCACC. H-Y/Db 3 RAG-22 3 D d
mice were obtained from the F3 generation of an intercross be-257 Cruz et al.
tween H-Y/Db 3 RAG-22 mice and BALB/c mice. Staining of
peripheral blood from the progeny with mAbs to Kd and Kb class
I molecules confirmed the MHC haplotype, and negative results
from staining with mAbs to CD4 confirmed the RAG-22/2 sta-
tus. PCR typing was used to identify the TCR transgene as de-
scribed above. All mice were housed under specific pathogen–
free conditions in the UCLA Center for Health Sciences vivarium.
Mice were analyzed between 8 and 20 wk of age.
Preparation of Lymphocytes. Thymus and LNs were excised,
and single cell suspensions were prepared by grinding the organs
between the frosted ends of two glass slides in complete RPMI
1640 medium with 5% FCS. Isolation of IEL was performed as
described previously (28), with minor modifications. In brief,
small and large intestines were removed and separated from me-
sentery and Peyer’s patches. They were cut longitudinally and
then into 0.5-cm pieces. The pieces were shaken three times for
20 min in Mg21-free, Ca21-free HBSS (Life Technologies, Inc.,
Gaithersburg, MD) supplemented with 1 mM dithiothreitol
(Sigma Chemical Co., St. Louis, MO). Cells were collected from
these washes and passed over a discontinuous 40/70% Percoll
(Pharmacia Biotech, Piscataway, NJ) gradient at 900 g for 20 min.
IEL were then isolated from the Percoll-gradient interface,
washed free of Percoll, and counted by light microscopy.
Flow Cytometric Analysis. The following mAbs were used for
phenotypic analysis of lymphocytes: PE-labeled or biotinylated
Vb8.1 and 8.2 (clone MR5-2), FITC- or PE-labeled or biotiny-
lated anti-CD8a clone 53-6.7, FITC- or PE-labeled anti-CD8b
clone 53-5.8, PE-labeled or biotinylated anti-Kb clone AF6-88.5,
biotinylated anti-Kd clone SF1-1.1, FITC- or PE-labeled anti-
CD4 clone GK1.5, and FITC-labeled anti-aE integrin clone
M290. All of the above were purchased from PharMingen (San
Diego, CA). Hybridoma cells producing the clonotypic antibody
(T3.70) that recognizes the transgenic TCR a chain were a gift
of Dr. B.J. Fowlkes, National Institutes of Health. Secondary re-
agents used included FITC-labeled anti–mouse IgG1 clone A85-1
(PharMingen) as a secondary antibody against the mouse T3.70
antibody, and streptavidin coupled to tricolor (Caltag Laborato-
ries, Inc., South San Francisco, CA) was used for all biotinylated
antibodies. For staining, cells were suspended in buffer composed
of PBS, pH 7.3, with 2% (wt/vol) BSA, 0.02% NaN3. mAbs
were added at a predetermined concentration that gave optimal
staining. Cells were incubated at 48C for 20 min with the primary
mAb, washed twice, and then incubated with secondary reagents
for another 20 min at 48C. Cells were analyzed on a FACScanÒ
440 flow cytometer (Becton Dickinson, San Jose, CA) at the Jons-
son Cancer Center Flow Cytometry Core Facility, UCLA (or the
La Jolla Institute for Allergy and Immunology). Viable lympho-
cytes were gated by forward and side angle light scatter parame-
ters, and the number in each subset of IEL was determined by
multiplying the number of total IEL by the percentage obtained
by staining after gating on either total or TCR1 lymphocytes.
The total number of IEL obtained was determined by counting
lymphocytes that excluded trypan blue in a hemacytometer.
Proliferation and IFN-g Release Assays. IEL isolated from small
intestine of male H-Y/Db 3 RAG-22 transgenic mice were
stained with anti-CD8a and anti-CD8b mAbs and then sorted
with a FACStarÒ fluorescence-activated cell sorter (Becton Dick-
inson) in order to obtain a highly enriched (.98% pure)
CD8aa1 IEL population. 105 CD8aa1 IEL or total lymphocytes
isolated from LN of female H-Y/Db transgenic mice were cul-
tured in RPMI supplemented with 12 U of recombinant human
IL-2 and 5% FCS in plates that had been coated with 5 mg/ml of
anti-CD3 mAb (2C11; PharMingen) or anti-gd TCR clone
UC7. Cells were cultured for 48 h, pulsed with 1 mCi [3H]thy-
midine, and harvested 24 h later. Proliferation levels are expressed
as mean 6 SEM of culture triplicates. For the IFN-g release as-
says, cells were cultured in triplicate in a similar manner except
that 100 ml of supernatant was withdrawn after 48 h of culture.
The IFN-g levels in the supernatants were detected using a sand-
wich ELISA with a coated capture mAb (purified R4-6A2) and a
biotinylated detection mAb (XMG1.2) according to the manu-
facturer’s protocol (PharMingen). Cytokine levels are expressed
as mean OD 6 SEM of culture triplicates.
Results
Generation of a TCR Monoclonal IEL Population. H-Y/Db
transgenic mice were crossed onto the RAG-22/2 back-
ground in order to completely eliminate rearrangement of
endogenous a, b, g, and d TCR genes. Expression of the
H-Y/Db–specific TCR was examined by two-color flow
cytometry analysis with the T3.70 mAb, which recognizes
the transgene-encoded Va3 chain, and with the M35-2
mAb, which recognizes Vb8.1- and Vb8.2-containing
TCRs. In contrast to the results obtained from mice not on
the RAG-2–deficient background, all of the peripheral LN
T cells in both male and female TCR transgenic mice ex-
pressed only the H-Y/Db–specific TCR (Fig. 1 A). Simi-
larly, all of the TCR1 small intestine IEL in male and fe-
male TCR transgenic mice expressed only the a and b
chains encoded by the TCR transgenes (Fig. 1 B). Al-
though the percentage of TCR1 cells obtained from differ-
ent sources varies, among the TCR1 cells the level of ex-
pression of both TCR chains is approximately similar. This
is significant, because in small intestine IEL of female H-Y/
Db transgenic mice which are not RAG-22/2, heteroge-
neous levels of expression of the TCR a transgene are
found, most likely reflecting the rearrangement and coex-
pression of endogenous TCR a genes (22).
Figure 1. T cells from male and female H-Y/Db 3 RAG-22 mice ex-
press only the transgenic TCR. Male and female lymphocytes isolated
from LNs (A) and IEL (B) were stained with the T3.70 mAb followed by
anti–mouse IgG1-FITC antibody. Cells were then stained with anti–
Vb8-PE. Data from 15-wk-old mice are shown, representative of all such
mice ages 8–20 wk analyzed. The percentage of cells positive for both the
TCR transgenes is indicated in the upper right quadrant.258 Differential Selection of IEL
Opposite Patterns of T Cell Selection Are Observed in the
Thymus and Intestine. As noted above, when Db molecules
are expressed by thymic epithelial cells, this has been reported
to lead to the positive selection of thymocytes expressing
the H-Y/Db TCR transgene in female mice, and to the
negative selection of these same T cells in male mice (22).
Consistent with these results, the thymus of male H-Y/Db 3
RAG-22 transgenic mice contains relatively few cells (Fig.
2), and the double positive population is greatly reduced in
number (data not shown). However, opposite to the pat-
tern observed in the thymus, H-Y/Db transgenic 3 RAG-22
male mice have relatively large numbers of TCR1 cells in
IEL obtained from the small intestine, whereas the small in-
testine epithelium of their female counterparts is severely
hypocellular with respect to lymphocytes (Fig. 2). Strik-
ingly, of the few IEL isolated from female H-Y/Db 3
RAG-22 mice, the majority did not express the TCR
transgene (Fig. 1 B). By contrast, in H-Y/Db transgenic 3
RAG-22 male mice, the proportion of TCR1 small intes-
tine IEL (Fig. 1 B) is equal to or greater than that typical of
nontransgenic mice. Male TCR transgenic mice also have
increased numbers of lamina propria lymphocytes (LPL)
from the small intestine compared with female TCR trans-
genic mice, the increase averaging 15-fold (n 5 3) when
age matched mice were analyzed. The difference between
male and female TCR transgenic mice was more modest in
the LPL than that seen in small intestine IEL, which had
z90 times more TCR1 cells in male transgenic than in fe-
male transgenic mice (Table 1). This difference between
small intestine IEL and LPL in TCR1 cell numbers may
reflect the presence of substantial numbers of circulating T
cells in female mice, and the more extensive colonization
by these circulating T cells of the lamina propria compared
with the epithelium (8). By contrast, in the large intestine,
there was little difference in the number of IEL and LPL
when male and female TCR transgenic mice were com-
pared, and the total number of lymphocytes in H-Y/Db
transgenic 3 RAG-22 mice tended to be less than the
number in nontransgenic mice (data not shown). In sum-
mary, the small intestine IEL compartment appeared to be
unique in the mucosa with regard to the differentiation
and/or expansion of TCR transgene1 lymphocytes in male
mice.
Selection of the TCR Transgene Does Not Occur in IEL
of H-Y/Db Transgenic 3 RAG-22 Female Mice. Although
H-Y/Db transgenic 3 RAG-22 female mice contain circu-
lating TCR transgene1 CD8ahighbhigh T cells in the pe-
riphery as a result of positive selection in the thymus, sur-
prisingly, relatively few TCR transgene1 CD8ab IEL are
present in IEL from the small intestines of these mice (Fig.
3 A, and Table 1). The number of TCR1 CD8ab1 IEL
Figure 2. Opposite patterns of T cell selection are observed in the thy-
mus and intestine of H-Y/Db transgenic 3 RAG-22 mice. Thymocytes
and small intestine IEL were stained for TCR transgene expression with
either Vb8-PE, or Vb8-biotin followed by streptavidin-tricolor. The
number of TCR transgene1 cells was calculated by multiplying the total
number of lymphocytes by the percentage of Vb81 cells as determined by
flow cytometry analysis. Each symbol represents the analysis of cells from
a single mouse. Values are as follows: female thymus (n 5 3), 3.4 3 108 6
0.03; male thymus (n 5 7), 4.0 3 106 6 0.9; female small intestine (n 5
6) 7.7 3 104 6 1.5; and male small intestine (n 5 9), 1.3 3 107 6 0.3.
Table 1. Number of IEL within Each Subset Isolated from H-Y/Db 3 RAG-22 and H-Y/Db 3 RAG-22 3 TAP-12 Mice
H-Y/Db 3 RAG-22 H-Y/Db 3 RAG-22 3 TAP-12
Male Female Male Female
n 5 3n  5  3n  5  2n  5  2
TCR1 (3 103) 8,220 6 2,428 93 6 13 11 6 3.3 7 6 2.7
CD8aa (3 103) 6,556 6 1,933 3 6 0.6 4 6 1.7 2 6 1.4
CD8ab (3 103) 540 6 186 6 6 2.6 ND ND
DN (3 103) 1,043 6 299 83 6 11 6 6 0.5 4 6 1.1
TCR2 (3 103) 140 6 37 257 6 63 119 6 67 45 6 16
Data from male and female H-Y/Db transgenic 3 RAG-22 mice were obtained from individual 15-wk-old littermates, all analyzed on the same day.
H-Y/Db transgenic 3 RAG-22 3 TAP-12 mice were analyzed as 8-wk-old individuals on the same day. The number of cells in each subset was
calculated as described in Materials and Methods.259 Cruz et al.
isolated from the small intestine of female mice averaged
only 6 3 103 in the set of animals of matched age analyzed
in Table 1. This is z100-fold less than the number re-
ported in female TCR transgenic mice that are not RAG-
22/2 (22), suggesting that in the presence of a functional
RAG-2 gene, IEL coexpressing both the a transgene and
an endogenous a gene had expanded. Female TCR trans-
genic mice also contain only a very few TCR1 CD8aa1
IEL (Fig. 3 A, and Table 1). These findings clearly show
that the earlier reported selection of TCR transgene1
CD8aa1 IEL in small intestine IEL of H-Y/Db transgenic
female mice that were not on the RAG-22/2 background
was probably due to the coexpression of endogenous TCR
a chains (22).
Small intestine IEL from female TCR transgenic mice
are predominantly CD32 cells (Fig. 3 A, and Table 1), with
some TCR1 DN cells. The exact number of such CD32
IEL is difficult to determine because there may be some
contaminating nonlymphoid cells that fall into the lympho-
cyte light scatter gate. However, the majority of the CD32
cells from female H-Y/Db transgenic 3 RAG-22 mice
stain positively for CD69 (data not shown), and it therefore
is likely that the majority belong to the lymphoid/he-
mopoietic lineages.
Although the very small number of TCR transgene1
IEL in female mice is consistent with an inefficient positive
selection of these cells, it more likely reflects the complete
lack of positive selection. A few peripheral T cells or short-
term residents of the epithelium could have been obtained
in the IEL preparation. Although proportionally few such
cells might be present in IEL from normal mice, in the set-
ting of the severely hypocellular IEL compartment of fe-
male H-Y/Db 3 RAG-22 transgenic mice, such a popula-
tion could be numerically very significant. To investigate
the possible origin of these cells in female mice, IEL were
stained with mAbs specific for Vb8, CD8b, and the aE
subunit of the mucosa-specific integrin. This mucosa-spe-
cific integrin is expressed on nearly all subpopulations of
IEL, but it is expressed much less frequently by circulating
T cells (29, 30) and is absent from LN T cells of H-Y/Db
transgenic 3 RAG-22 mice (data not shown). Fig. 3 B
shows two-color flow cytometry data on cells gated for
Vb8 expression. In H-Y/Db transgenic 3 RAG-22 female
mice, most TCR1 IEL, including the few that are CD8b1
and that might constitute the positively selected subset de-
rived from the thymus, are aE negative. This lack of aE ex-
pression in TCR transgene1 IEL from female mice is con-
sistent with these cells being contaminants from blood, or
with them being recent emigrants and transient residents of
the epithelial compartment. Thus, in the absence of endog-
enous TCR rearrangement, female mice cannot support
the selection and/or expansion of CD8ab1 IEL expressing
the H-Y/Db–specific TCR transgene.
Class I Molecules Are Required for the Selection of TCR
Transgene1 IEL. The decreased number and largely CD82
and/or TCR2 phenotype of small intestine IEL in H-Y/Db
transgenic 3 RAG-22 female mice suggested that cells ex-
pressing the TCR transgene failed to undergo positive se-
lection. To determine if this is the case, we also analyzed
IEL from H-Y/Db TCR 3 RAG-22 transgenic mice that
lack expression of the Db class I molecule, a situation in
which positive selection of the TCR transgene should not
occur either in male or in female mice. To do this, H-Y/Db
TCR transgenic 3 RAG-22 mice were bred either to
TAP-12/2 mice, in order to generate TCR transgenic
mice doubly deficient for both the expression of classical
class I molecules and for endogenous V gene rearrangement,
or to the nonselecting H-2d background. Consistent with
the requisite role of class I molecules in the thymic positive
selection of peripheral CD8ab1 T cells (9), H-Y/Db TCR
transgenic 3 RAG-22 3 TAP-12 male and female mice
lack TCR transgene1, CD81 thymocytes, although they
contain a few TCR1 DN peripheral T cells (data not
shown). Similarly, without the expression of TAP-depen-
dent classical class I molecules, TCR transgene1 small in-
testine IEL are greatly reduced in number in either male
(Fig. 4 A, and Table 1) or female mice (Fig. 4 B, and Table
1). The remaining few TCR1 cells in mice of both sexes
are either DN or CD8aa1. The very small population of
TCR1 CD8ab1 IEL, described above, which is present in
female Db1 H-Y/Db transgenic 3 RAG-22 mice, is com-
pletely absent in TCR transgenic mice that are also TAP-
1–deficient (Table 1). Furthermore, a specific interaction
of the TCR with the selecting Db molecule is required, as
H-Y/Db TCR transgenic 3 RAG-22 male mice on the non-
Figure 3. CD8aa1 and CD8ab1 IEL develop more efficiently in male
than in female H-Y/Db transgenic mice. Three-color flow cytometry anal-
ysis was used to determine coreceptor expression by TCR1 cells in small
intestine IEL preparations. (A) IEL from male transgenic mice express
predominantly CD8aa homodimers, whereas the majority of female IEL
are DN. The analysis of CD8 coreceptor expression is shown for TCR
transgene1 (Vb81) cells from individual mice. Representative data from
one of many different experiments are shown. (B) The TCR1 IEL that
express CD8b in the females do not coexpress the aE integrin. The anal-
ysis of CD8b and aE expression is shown for Vb81 cells from individual
mice. Representative data from one of two mice analyzed in this way.260 Differential Selection of IEL
selecting Dd background also fail to support the develop-
ment of more than just a very few TCR transgene1 IEL,
similar to the greatly reduced cell numbers observed in IEL
from H-Y/Db TCR transgenic 3 RAG-22 3 TAP-12
mice (Fig. 4 C). Other than the presence of a few CD8b1
cells in female TCR transgenic Db mice, the greatly re-
duced number and TCR2 phenotype of the IEL in Db1 fe-
male mice is similar to that in mice that do not express se-
lecting class I molecules. However, female Db1 mice do
contain increased numbers of TCR transgene1 DN IEL
compared with their Db2 counterparts, but the total cell
numbers are quite low in both kinds of animals.
TCR1 IEL in Male H-Y/Db TCR Transgenic 3 RAG-22
Mice Have Unusual Patterns of Coreceptor Expression. In male
H-Y/Db TCR transgenic mice, T cells in the periphery are
either TCR transgene1 and DN, or TCR transgene1 and
CD8alowblow (15, 16). Both of these populations are unre-
sponsive to male antigen (16). By contrast, there are three
patterns of coreceptor expression in TCR transgene1 small
intestine IEL of male H-Y/Db 3 RAG-22 transgenic mice;
only one of these, the DN subset, is also found in periph-
eral lymphoid tissues.
The major cell population in small intestine IEL of TCR
transgenic male mice expresses a relatively high amount of
CD8aa homodimers (Fig. 3 A, and Table 1). The level of
CD8a expression on these IEL is higher than that ex-
pressed by the major population of peripheral CD8alowblow
T cells in these male TCR transgenic mice, and it is nearly
comparable to the level seen in female LN or spleen
cells (Fig. 5 A). There are no detectable cells with this
CD8aahigh phenotype in either spleen or LNs of male mice
(Fig. 5 A).
Interestingly, in H-Y/Db TCR transgenic 3 RAG-22
male mice, there are nearly 100-fold more small intestine
IEL that are CD8ab1 than in TCR transgenic females
(Table 1). This population was not observed previously in
H-Y/Db transgenic male mice that are not on the RAG-
22/2 background (22). However, the majority of these
CD8ab1 cells are unique in that they express high levels of
CD8a (Figs. 3 A and 5 A), comparable to the levels ex-
pressed by the CD8aa1 cells, along with relatively low
levels of CD8b (Figs. 3 A and 5 B). Such a combination
suggests that CD8ahighblow IEL express both CD8aa ho-
modimers and CD8ab heterodimers on their cell surface.
By contrast to the CD8ab1 cells in the female small intes-
tine, most of the CD8ab1 cells in the male small intestine
express aE integrin (Fig. 3 B), suggesting that they are
likely to be long-term residents of the epithelial compart-
ment.
In addition, male H-Y/Db 3 RAG-22 mice on the Db
background contain significant numbers of TCR transgene1
DN IEL in the small intestine. The number of DN IEL is
increased substantially compared with the numbers present
in small intestine IEL of female mice with the same MHC
haplotype, or TCR transgenic mice on either one of the
nonselecting MHC haplotypes we tested (Table 1). Finally,
in the presence of endogenous TCR gene rearrangements,
a substantial frequency of CD41 and CD41, CD8aa1 IEL
were reported in H-Y/Db transgenic mice (21, 22). By
Figure 4. Phenotype of small intestine IEL in TCR transgenic mice that
lack expression of the positively selecting class I molecule. (A) IEL from
an individual H-Y/Db 3 RAG-22 3 TAP-12 25-wk-old male mouse.
(B) IEL from an individual H-Y/Db 3 RAG-22 3 TAP-12 25-wk-old
female mouse. (C) IEL from an individual 18-wk-old Dd1 H-Y/Db 3
RAG-22 male mouse. Isolated IEL were stained with anti-CD8a, anti-
CD8b, and anti-Vb8 mAbs, and the two-color dot plots for CD8a and
Vb8 expression are displayed. There were no cells positive for CD8b
staining in these nonselecting TCR transgenic mice. Data from these
mice, which are slightly older than the average, were collected on a dif-
ferent day, and were not used in the compilation of TAP-12/2 mice in
Table 1.
Figure 5. Levels of CD8 coreceptor expression by T cells from H-Y/
Db 3 RAG-22 transgenic mice. (A) CD8a staining. Cells obtained from
the indicated sources from individual mice were stained for Vb8-biotin
and CD8a-PE, and the single-color CD8 histogram is shown for the
Vb81 cells. (B) CD8b staining, determined with a CD8b-PE mAb, for
the same individuals as described above for CD8a. Representative data
from one of many experiments. MF, Mean fluorescence.
Figure 6. CD41 IEL are absent in H-Y/Db 3 RAG-22 mice. Total
IEL, with the lymphocyte gate set according to light scatter parameters,
from individual male and female mice were stained with anti-CD4–FITC
and anti–Vb8-biotin, followed by streptavidin-tricolor. Representative
data from one of many experiments are presented.261 Cruz et al.
contrast, there is no significant expression of CD4 on IEL
in either male or female H-Y/Db transgenic 3 RAG-22
mice (Fig. 6).
It is possible that the TCR transgene1 T cells in IEL of
male mice are derived from T cells circulating in the pe-
riphery. Although the CD8aa1 and CD8ahighblow pheno-
types of the male IEL in transgenic mice are not found in
circulating T cells, the migration of T cells to the intestine
could cause an upregulation in CD8a coreceptor expres-
sion leading to the generation of CD8aa1 IEL from DN
cells, and CD8ahighblow IEL from the CD8alowblow cells.
These hypothetical changes in CD8a expression are analo-
gous to the behavior of splenic or LN CD41 T cells, which
after transfer to SCID mice, can migrate to the intestine
and acquire CD8aa homodimers (31–33). However, in
contrast to the results derived from the transfer of CD41 T
cells, when splenic or LN lymphocytes obtained either
from male or female transgenic mice were transferred to ei-
ther male or female Db1 SCID mice, we could not detect
donor-derived IEL in the intestine of multiple SCID recip-
ients (data not shown). However, this is not due to an in-
trinsic defect in intestinal homing by CD8 T cells after
SCID transfer, as polyclonal CD81 splenic T cells can mi-
grate to the intestine after transfer to a SCID host (33).
Therefore, we consider it unlikely that circulating T cells in
male transgenic mice give rise to the majority of IEL in
these animals.
CD8aa1 IEL in Male Transgenic Mice Are Not Anergic.
We analyzed the functional state of the CD8aa1 IEL in
male TCR transgenic mice, the major small intestine IEL
population in these individuals, to determine if these T
lymphocytes had been tolerized as a result of exposure to
male antigen. Anergy has been reported to be a major
mechanism for self-tolerance induction of TCR gd1 IEL
(34), and the oligoclonal TCR ab1 CD8aa1 IEL from
normal mice have been reported to express self-reactive Vb
chains and to be relatively anergic when stimulated in vitro
(35–38). The CD8aa1 IEL were enriched by flow cytom-
etry and were .98% pure (data not shown). Upon CD3
cross-linking, these IEL proliferate to a similar degree as do
LN T cells isolated from female H-Y/Db transgenic mice
(Fig. 7 A). In addition, in comparison to LN cells from fe-
male H-Y/Db transgenic mice, CD8aa1 IEL from male
transgenic mice are also able to produce similar levels of
IFN-g in response to CD3 cross-linking (Fig. 7 B). Despite
their ability to respond to TCR-mediated signals in vitro
and in agreement with previously published results (22),
CD8aa1 IEL from male transgenic mice are unable to
proliferate, even in the presence of added IL-2, in response
to H-Y antigen–bearing splenocytes (data not shown).
Discussion
We have used transgenic mice that are monoclonal for
the expression of a TCR specific for an H-Y peptide pre-
sented by Db to analyze the development and selection of
IEL. As noted above, previous analyses of these same TCR
transgenic mice, which were not on the RAG-22/2 back-
ground, led to conclusions that were not entirely in agree-
ment (21–23). This is probably due to the significant level
of rearrangement of endogenous TCR a genes in this
TCR transgenic model, and the phenotypic complexity of
mouse small intestine IEL subpopulations. Phenotypic com-
plexity is inherent to IEL, as even in truly monoclonal male
TCR transgenic mice on the RAG-22/2 background, we
found three significant subpopulations of TCR transgene1
cells, including DN, CD8aa1, and CD8ahighblow IEL.
Nevertheless, analysis of lymphocytes in these TCR mono-
clonal mice has allowed us to resolve inconsistencies in the
prior studies and to provide an explanation for the distinct
selective processes in IEL.
A major finding in this report is that the pattern of selec-
tion of a single TCR is different when thymus-selected pe-
ripheral lymphocytes are compared with small intestine
IEL. Although the H-Y/Db TCR is positively selected in
the thymus of female mice, it fails to be selected in their
IEL. IEL in female H-Y/Db transgenic mice on the Db1 se-
lecting background are similar in number and phenotype to
the IEL numbers in H-Y/Db transgenic mice that are Db
negative. The paucity of IEL in female transgenic mice is
also consistent with a possible negative selection of TCR
transgene1 cells, but it is very difficult to believe this could
occur in female mice. It is noteworthy that lymphocytes from
the population of circulating TCR transgene1 CD8ab1 T
cells in female transgenic mice do not migrate to the IEL
compartment. Because of the absence of male antigen in
these mice, this observation is consistent with recent find-
ings indicating that antigenic stimulation is likely to be an
important determinant fostering the migration of circulat-
Figure 7. The CD8aa IEL subset from male H-Y/Db 3 RAG-22
mice can respond to CD3 cross-linking. CD8aa IEL were highly puri-
fied by cell sorting as described in Materials and Methods from a pool of
two mice. Small intestine IEL from male mice, or total lymphocytes iso-
lated from LNs of female H-Y/Db transgenic mice, were cultured in
plates that had been coated either with 5 mg/ml of anti-CD3 mAb
(2C11) or with a control hamster mAb (anti-gd clone UC7) as described
in Materials and Methods. Data are from triplicate wells in each case, with
the SE of the mean indicated. (A) Proliferation assay. Cells were cultured
for 48 h, pulsed with [3H]thymidine, and harvested 24 h later. (B) IFN-g
release. Cells were cultured for 48 h as described above, and then super-
natants were assayed for cytokine release by ELISA as detailed in Materials
and Methods.262 Differential Selection of IEL
ing T cells to the intestinal epithelium and their long-term
residence in that location (39, 40).
In contrast to the IEL in female transgenic mice, in male
mice, IEL expressing the TCR transgene seem to undergo
a selection process that could be similar to positive selec-
tion. Positive selection is a process in which immature T
cells are tested for the expression of TCRs with an appro-
priate specificity, with cells undergoing programmed cell
death unless they express the correct coreceptor and have a
low affinity recognition of a self–MHC molecule plus se-
lecting self-peptide in the absence of foreign antigen (1).
After maturation, the selected T cells do not respond to
doses of the positively selecting peptide(s) equivalent to those
in the thymus. Positive selection in IEL of male transgenic
mice is consistent with the large numbers of IEL that ex-
press the TCR transgene, the majority of which also have
relatively high levels of CD8aa homodimers. The pres-
ence of large numbers of TCR transgene1 CD8aa1 IEL
requires both Db and the male antigen, suggesting that
these are positively selected cells rather than immature pre-
cursors. Consistent with this, in vitro studies indicate that
the CD8aa1 IEL from male transgenic mice are capable of
responding to TCR-mediated signals, although they do not
respond to H-Y1 stimulator cells. Therefore, although in
some studies the oligoclonal CD8aa1 IEL from normal mice
were relatively poor responders to TCR-mediated stimula-
tion (35–38), these data clearly demonstrate that some
CD8aa1 IEL can respond vigorously to such stimulation.
Our findings on the TCR responsiveness of CD8aa1 IEL
are more consistent with those from a recent study of the
2C TCR transgenic model, which demonstrated that at
least some CD8aa1 IEL are able to proliferate and secrete
cytokines in response to clonotypic antibodies (41).
However, it remains possible that extrathymic ab T
cells, including IEL, do not require a true positive selection
process, as has been proposed for differentiating gd T cells
(42). According to this view, maturing IEL might be al-
lowed to survive if they expressed any ab TCR, and these
cells could then be subjected to antigen-driven expansion
as mature T cells. This model would account for the near
complete absence of TCR transgene1 cells in female mice,
as well as for their expansion in Db1 male mice. However,
it should be noted that we and others could not detect re-
activity by TCR transgene1 CD8aa1 IEL for male stimu-
lator cells in vitro, and the male transgenic mice do not
show any histologic evidence for small intestine inflamma-
tion (data not shown), despite the presence of very large
numbers of potentially autoreactive T cells in their intes-
tine. Although these findings argue collectively against the
antigen-driven expansion model described above, it is for-
mally possible that a very weak antigenic stimulation in
vivo causes the gradual accumulation of large numbers of
TCR transgene1 small intestine IEL in the absence of an
overt inflammatory condition. Therefore, other than in the
discussion of models, we have used the word “selection,”
which encompasses both positive selection as well as anti-
gen-driven expansion, to describe the presence of large
numbers of functional TCR1 CD81 IEL in male trans-
genic mice.
The experiments in this report do not determine if the
TCR transgene1 IEL in male mice arise via an extrathymic
route, although we favor this possibility. In fact, years of
investigation on the origin of IEL have not fully resolved
this issue (43), which is complicated by the likely thymic
influence on the extrathymic differentiation pathway (44,
45). However, the CD8aa1 phenotype of the major pop-
ulation of IEL in male mice is consistent with a possible ex-
trathymic origin. The thymus-independent origin of the
CD8aa IEL subpopulation is supported by studies in
which adult thymectomized mice were given a source of
stem cells, including two more recent studies that avoided
irradiation of the host by using either RAG-22/2 recipients
or W/Wv recipients with reduced c-Kit receptor function
(46, 47). Furthermore, we could not generate these CD8aa1
IEL by transfer of circulating T cells from TCR transgenic
mice into SCID recipients. Therefore, we consider it un-
likely that the TCR and CD81 IEL in male transgenic
mice arise from circulating T cells that have entered the in-
testine, although it remains possible that the CD8aa1 and
CD8ahighblow cells in these mice have a thymic origin, and
that these cells are transported directly to the intestine after
thymic maturation.
Analysis of the expression of the CD4 and CD8 corecep-
tors in TCR monoclonal mice gives further insight into
IEL differentiation. Although it has been proposed that the
CD41 CD8aa1 double positive IEL are precursors of sin-
gle positive IEL, CD41 and CD41 CD8aa1 IEL are nearly
completely absent in the H-Y/Db 3 RAG-22 mice. By
contrast to IEL, double positive thymocytes can be found
in abundance in female Db1 transgenic mice, as well as on
thymocytes from mice of both sexes with a nonselecting
MHC haplotype (48). The lack of double positive IEL in
all mice studied, including those in which positive selection
of the TCR transgene cannot occur and those where it
might be fostered, suggests that the double positives are not
precursors of TCR transgene1 CD8 single positive IEL.
The population of CD8ahighblow IEL in male transgenic
mice has not been reported previously in studies of these
TCR transgenic mice. They are found only in Db1 male
TCR transgenic mice, and they are less numerous in these
mice than the CD8aa1 IEL. Interestingly, CD8ahighblow
IEL were reported recently in normal mice, and compared
with CD8ahighbhigh IEL, these cells were not highly sensi-
tive to the absence of b2 integrins or ICAM-1 (49). There
are several possible explanations for the origin of these
CD8ahighblow cells, but the implication is that high levels of
both CD8a and CD8b lead to negative selection, whereas
the CD8ahighblow phenotype permits survival.
All of the results on the selection of IEL that we have
presented in this report can be explained by a relatively
simple model, outlined in Fig. 8, which incorporates four
assumptions. First, the model presumes that some IEL are
derived from a separate group of cells than the mainstream
CD41 and CD8ab1 single positive T cells that mature in263 Cruz et al.
the thymus and that are found in spleen and LNs. It is fur-
ther presumed that mainstream T cells will only enter the
IEL compartment after antigenic stimulation. Second, as
discussed above, the model hypothesizes that the T cells in
this separate IEL lineage, distinct from the mainstream T
cells, require a true positive selection process, which may
occur either in the thymus or elsewhere. Third, the model
assumes that in these TCR transgenic mice, positive selec-
tion in female and male mice can be explained by the dif-
ferential avidity model, with high avidity leading to nega-
tive selection, low avidity leading to lack of selection, and
intermediate avidity leading to positive selection. Fourth,
the model assumes that it is the differences in the amount
and the type of CD8 coreceptor expressed that are the ma-
jor determinants of the differences between TCR selection
in male and female IEL and thymocytes. Indeed, it has
been demonstrated that the affinity of the CD8 coreceptor
can affect the avidity threshold for positive selection (50).
Furthermore, the results from several experiments indicate
an important role for CD8b in increasing the strength of
the CD8a-mediated signal, including data showing directly
that it can increase the avidity of the TCR–MHC class I
interaction (51, 52), that coexpression of CD8b can in-
crease the reactivity of mature CD8a1 T cells for antigen
(53, 54), and that CD8b is required for the positive selec-
tion of most CD81 T cells (55–57).
Interpreted in the context of this model, it is possible
that the expression of the CD8aa coreceptor in IEL leads
to a decrease in the overall avidity of the interaction of the
H-Y/Db TCR with peptide plus class I. In male mice, this
would shift the avidity of this TCR from the range in
which negative selection occurs to the intermediate range
in which positive selection might occur (Fig. 8). Further-
more, CD8aa IEL would be able to persist in great num-
bers in the male intestine without any signs of autoreactiv-
ity, as a result of a decreased avidity of the TCR transgene
for H-Y peptide plus Db. By a similar reasoning, in female
mice, the expression of CD8aa coreceptors in the IEL-
specific lineage would decrease the overall avidity of this
H-Y/Db TCR from the positive selection range to an
avidity too low to support positive selection. The female
transgenic mice remain virtually devoid of IEL because, as
noted above, mainstream thymus-derived CD8ab1 T cells
in the female transgenic mice are not likely to enter the in-
testine without antigenic stimulation. This interpretation
emphasizing the importance of the CD8b chain is consis-
tent with the analysis of female H-Y/Db TCR transgenic
mice crossed onto a CD8b2/2 background, as in the ab-
sence of CD8b, positive selection of the H-Y/Db TCR
transgene is not supported (55). However, it should be
noted that male H-Y/Db TCR transgenic mice crossed
onto a CD8b2/2 background do not positively select large
numbers of TCR transgene1, CD8aa1 thymocytes (55).
This indicates that besides differences in coreceptor expres-
sion, additional factors might contribute to the differential
selection of this TCR transgene in IEL. Because the
CD8aa IEL express CD3 complexes containing FceRIg
chains, either as heterodimers with CD3z/h, or as ho-
modimers, although such CD3 complexes are not found
on CD8ab IEL (58, 59), FceRIg expression could be one
such factor important for the differentiation of the CD8aa
subpopulation.
In conclusion, the data presented here from female trans-
genic mice demonstrate that CD81 T cells positively se-
lected in the thymus will not necessarily be present in small
intestine IEL. We also provide data from male mice
strongly suggesting the opposite, namely that a CD81
TCR well represented among IEL need not be efficiently
selected in the thymus. Furthermore, the data demonstrate
that CD8aa IEL need not be anergic. The results from
both male and female mice give rise to a relatively simple
model for the differential selection of thymocytes and IEL,
based upon the expression of CD8aa coreceptors by IEL
and the expression of CD8ab coreceptors by thymocytes
and peripheral T cells derived from CD8 single positive
thymocytes. This differential selection model is consistent
with a previous analysis indicating that the predominant
clones in polyclonal CD8aa IEL populations are different
from the predominant clones in CD8ab IEL (60). Despite
these insights, the specificity and function of the oligo-
clonal TCR ab CD8aa1 IEL repertoire in normal mice,
as well as the reason for the expression of this form of CD8
in the intestine, remain to be determined.
Figure 8. A model for the opposite pattern of selection of the H-Y/Db
TCR in thymocytes and IEL. Top, Hypothetical plot of thymocyte num-
ber versus TCR avidity for self-MHC in a normal mouse. Most cells are
ignored and undergo programmed cell death as their TCRs fall into the
no selection avidity range (open area), while only a minority fall into the
range for positive selection (solid gray area). In the thymus of H-Y/Db 3
RAG-22 mice (middle), the avidity range of the monoclonal TCR popu-
lation that expresses CD8ab is very narrow, and falls into the positive se-
lection range for females and the high avidity negative selection range for
males (diagonal stripes). By contrast, in CD8aa1 IEL (bottom), the overall
avidity of the TCR interaction is shifted to the left because of the lower
avidity of the homodimeric form of CD8. This places the H-Y/Db TCR
in female mice in the no selection range, and in male mice in the positive
selection range.264 Differential Selection of IEL
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